|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Handok Pharmaceuticals Co., Ltd. |
|---|---|
| Information provided by: | Handok Pharmaceuticals Co., Ltd. |
| ClinicalTrials.gov Identifier: | NCT00261079 |
Purpose
Primary objective:
Secondary objective:
| Condition | Intervention | Phase |
|---|---|---|
|
Pruritus |
Drug: Fexofenadine |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | The Evaluation of Efficacy and Safety of Fexofenadine 180mg Tablets for 7 Days in the Treatment of Pruritic Skin Disease |
Eligibility| Ages Eligible for Study: | 12 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
The following information on clinical trials is provided for information purposes only to allow patients and physicians to have an initial discussion about the trial. This information is not intended to be complete information about the trial, to contain all considerations that may be relevant to potential participation in the trial, or to replace the advice of a personal physician or health professional.
Main criteria are listed hereafter:
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | M016455_4125 |
| Study First Received: | December 1, 2005 |
| Last Updated: | November 5, 2007 |
| ClinicalTrials.gov Identifier: | NCT00261079 History of Changes |
| Health Authority: | South Korea: Korea Food and Drug Administration (KFDA) |
|
Pruritus Neurotransmitter Agents Histamine Antagonists Skin Diseases Fexofenadine |
Histamine phosphate Histamine H1 Antagonists Anti-Allergic Agents Histamine |
|
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Histamine Antagonists Skin Diseases Therapeutic Uses Physiological Effects of Drugs |
Fexofenadine Histamine Agents Histamine H1 Antagonists Anti-Allergic Agents Histamine H1 Antagonists, Non-Sedating Pharmacologic Actions |